These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12753731)

  • 21. The impact of clinical pharmacist in a cardiac-surgery intensive care unit.
    Al-Jazairi AS; Al-Agil AA; Asiri YA; Al-Kholi TA; Akhras NS; Horanieh BK
    Saudi Med J; 2008 Feb; 29(2):277-81. PubMed ID: 18246241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda.
    Marseille E; Saba J; Muyingo S; Kahn JG
    AIDS; 2006 Apr; 20(6):907-14. PubMed ID: 16549976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.
    Palmer AJ; Roze S; Valentine WJ; Minshall ME; Foos V; Lurati FM; Lammert M; Spinas GA
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S5-26. PubMed ID: 15324513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Principal findings from the Washington State cognitive services demonstration project.
    Christensen DB; Holmes G; Fassett WE; Neil N; Andrilla CH; Smith DH; Andrews A; Bell EJ; Hansen R; Shafer R; Stergachis A
    Manag Care Interface; 1998 Jul; 11(7):60-2, 64. PubMed ID: 10181572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic combinations with redundant antimicrobial spectra: clinical epidemiology and pilot intervention of computer-assisted surveillance.
    Glowacki RC; Schwartz DN; Itokazu GS; Wisniewski MF; Kieszkowski P; Weinstein RA
    Clin Infect Dis; 2003 Jul; 37(1):59-64. PubMed ID: 12830409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study to document the return on investment for implementing an ambulatory electronic health record at an academic medical center.
    Grieger DL; Cohen SH; Krusch DA
    J Am Coll Surg; 2007 Jul; 205(1):89-96. PubMed ID: 17617337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating resource use and cost of prophylactic management of neutropenia with filgrastim.
    Annemans L; Van Overbeke N; Standaert B; Van Belle S
    J Nurs Manag; 2005 May; 13(3):265-74. PubMed ID: 15819840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plan-sponsor savings and member experience with point-of-service prescription step therapy.
    Motheral BR; Henderson R; Cox ER
    Am J Manag Care; 2004 Jul; 10(7 Pt 1):457-64. PubMed ID: 15298367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An alternative approach to reducing the costs of patient care? A controlled trial of the multi-disciplinary doctor-nurse practitioner (MDNP) model.
    Ettner SL; Kotlerman J; Afifi A; Vazirani S; Hays RD; Shapiro M; Cowan M
    Med Decis Making; 2006; 26(1):9-17. PubMed ID: 16495196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of an ambulatory care clinical pharmacist: a controlled trial.
    Mason JD; Colley CA
    Ann Pharmacother; 1993 May; 27(5):555-9. PubMed ID: 8347901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model.
    Nesbit TW; Shermock KM; Bobek MB; Capozzi DL; Flores PA; Leonard MC; Long JK; Militello MA; White DA; Barone LD; Goldman MP; Kvancz DA
    Am J Health Syst Pharm; 2001 May; 58(9):784-90. PubMed ID: 11351918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacist value-added to neuro-oncology subspecialty clinics: A pilot study uncovers opportunities for best practices and optimal time utilization.
    Lee GW; Mathur AD; Andrick BJ; Leese E; Zally D; Gatson NTN
    J Oncol Pharm Pract; 2020 Dec; 26(8):1937-1941. PubMed ID: 32938297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost savings and avoidance from clinical interventions.
    Mutnick AH; Sterba KJ; Peroutka JA; Sloan NE; Beltz EA; Sorenson MK
    Am J Health Syst Pharm; 1997 Feb; 54(4):392-6. PubMed ID: 9043561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of a pediatric clinical pharmacist in the pediatric intensive care unit.
    Krupicka MI; Bratton SL; Sonnenthal K; Goldstein B
    Crit Care Med; 2002 Apr; 30(4):919-21. PubMed ID: 11940770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling the cost and outcomes of pharmacist-prescribed emergency contraception.
    Marciante KD; Gardner JS; Veenstra DL; Sullivan SD
    Am J Public Health; 2001 Sep; 91(9):1443-5. PubMed ID: 11527778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Palliative care pharmacist interventions in a community hospital.
    Naidu D; Jones K; Kanyer D; Hausdorff J
    Am J Health Syst Pharm; 2018 Jul; 75(13):933-936. PubMed ID: 29941533
    [No Abstract]   [Full Text] [Related]  

  • 37. Preliminary data from a pharmacist-managed anticoagulation clinic embedded in a multidisciplinary patient-centered medical home: a coordinated quality, cost-savings model.
    Garwood CL; Curtis KD; Belanger GJ; Cardozo LJ; Turlo GE; Steinberg JD; Lepczyk M
    J Am Geriatr Soc; 2014 Mar; 62(3):536-40. PubMed ID: 24512304
    [No Abstract]   [Full Text] [Related]  

  • 38. Pill splitting cuts rx costs but can pose medical risks.
    Pa Health You; 2002; 105(3):13. PubMed ID: 12373793
    [No Abstract]   [Full Text] [Related]  

  • 39. The critical care pharmacist: what you get is more than what you see.
    Dasta JF; Jacob J
    Crit Care Med; 1994 Jun; 22(6):906-9. PubMed ID: 8205822
    [No Abstract]   [Full Text] [Related]  

  • 40. Splitting pills OK in certain cases.
    Health News; 2002 Nov; 8(11):9. PubMed ID: 12523256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.